文献速递生殖医学产科母胎医学

激素替代周期与妊娠期高血压疾病风险升高相关:单胎与双胎妊娠的回顾性队列研究

Hormone replacement cycles are associated with a higher risk of hypertensive disorders: Retrospective cohort study in singleton and twin pregnancies.
PubMed 文献 · BJOG · 2022-11-24

基于瑞士IVF注册库2014至2019年单胎(n=4636)和双胎(n=544)活产数据,比较自然周期、刺激周期和激素替代周期冻融胚胎移植后的妊娠结局。单胎妊娠中激素替代周期与自然周期相比,早期阴道出血、孤立性高血压和子痫前期的校正比值比均升高。

要点

  • 单胎妊娠中激素替代周期较自然周期,早期阴道出血aOR 2.23、孤立性高血压aOR 2.50、子痫前期aOR 2.16。
  • 单胎妊娠中激素替代周期较刺激周期,早期阴道出血aOR 2.08、子痫前期aOR 6.02。
  • 双胎妊娠中激素替代周期的子痫前期发生率最高,但数值上的比值比未达统计学显著。

核心结论

  • 数据提示激素替代周期冻融胚胎移植的妊娠期高血压疾病风险最高,因此若医学上可行,临床医生应优先选择刺激周期或自然周期冻融胚胎移植。

研究设计与样本

  • 基于人群的注册研究,数据来自瑞士IVF注册库,纳入2014年至2019年注册的单胎(n=4636)和双胎(n=544)活产。
  • 按周期方案分为自然周期冻融胚胎移植(n=776)、刺激周期冻融胚胎移植(n=758)和激素替代周期冻融胚胎移植(n=3646)。
  • 采用混合模型分析15种妊娠病理,校正周期方案、分娩、受精技术、慢性无排卵、母亲年龄和中心。

主要发现

  • 单胎妊娠中,激素替代周期较自然周期:早期阴道出血aOR 2.23(95%CI 1.33-3.75),孤立性高血压aOR 2.50(95%CI 1.02-6.12),子痫前期aOR 2.16(95%CI 1.13-4.12)。
  • 单胎妊娠中,激素替代周期较刺激周期:早期阴道出血aOR 2.08(95%CI 1.03-4.21),子痫前期aOR 6.02(95%CI 1.38-26.24)。
  • 双胎妊娠中,激素替代周期的子痫前期发生率最高,激素替代周期较自然周期和较刺激周期的子痫前期比值比在数值上更高。

关键数值与推荐

  • 单胎妊娠中,激素替代周期较自然周期早期阴道出血aOR 2.23(95%CI 1.33-3.75)。
  • 单胎妊娠中,激素替代周期较自然周期孤立性高血压aOR 2.50(95%CI 1.02-6.12)。
  • 单胎妊娠中,激素替代周期较自然周期子痫前期aOR 2.16(95%CI 1.13-4.12)。
  • 单胎妊娠中,激素替代周期较刺激周期早期阴道出血aOR 2.08(95%CI 1.03-4.21)。
  • 单胎妊娠中,激素替代周期较刺激周期子痫前期aOR 6.02(95%CI 1.38-26.24)。

临床怎么用

  • 作者认为若医学上可行,临床医生应优先选择刺激周期或自然周期冻融胚胎移植,而非激素替代周期。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To elaborate the associations of different cycle regimens (natural cycle [NC], stimulated cycle [SC], hormone replacement cycle [HRC]) on maternal and neonatal adverse pregnancy outcomes after frozen-thawed embryo transfers (FET). DESIGN: Population-based registry study. SETTING: Swiss IVF Registry. POPULATION OR SAMPLE: Singleton (n = 4636) and twin (n = 544) live births after NC-FET (n = 776), SC-FET (n = 758) or HRC-FET (n = 3646) registered from 2014 to 2019. METHODS: Fifteen pregnancy pathologies were modelled for singleton and twin pregnancies using mixed models adjusted for cycle regimen, delivery, fertilisation technique, chronic anovulation, age of mother and centre. MAIN OUTCOME MEASURES: Maternal (vaginal bleeding, isolated arterial hypertension and pre-eclampsia) and neonatal (gestational age, birthweight, mode of delivery) adverse pregnancy outcomes. RESULTS: In singleton pregnancies, the incidences of bleeding in first trimester, isolated hypertension and pre-eclampsia were highest in HRC-FET with doubled odds of bleeding in first trimester (adjusted odds ratio [aOR] 2.23; 95% CI 1.33-3.75), isolated hypertension (aOR 2.50; 95% CI 1.02-6.12) and pre-eclampsia (aOR 2.16; 95% CI 1.13-4.12) in HRC-FET vs. NC-FET and with doubled respectively sixfold odds of bleeding (aOR 2.08; 95% CI 1.03-4.21) and pre-eclampsia (6.02; 95% CI 1.38-26.24) in HRC-FET versus SC-FET. In twin pregnancies, the incidence of pre-eclampsia was highest in HRC-FET with numerically higher odds of pre-eclampsia in HRC-FET versus NC-FET and versus SC-FET. CONCLUSIONS: Our data implied the highest maternal risks of hypertensive disorders in HRC-FET, therefore clinicians should prefer SC-FET or NC-FET if medically possible.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Pape J, Levy J, von Wolff M, et al. Hormone replacement cycles are associated with a higher risk of hypertensive disorders: Retrospective cohort study in singleton and twin pregnancies. BJOG. 2022. PMID: 36371677. doi:10.1111/1471-0528.17343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。